Evidence map›Paper›PMID 40478202›Full record

ArticleJournal of cellular and molecular medicine2025

MIB2-Mediated SUZ12 Ubiquitination Regulates Clonal Proliferation in Patients With Paroxysmal Nocturnal Haemoglobinuria.

Hui Liu, Lijie Zeng, Chaomeng Wang, Yingying Chen, Liyan Li, Zhaoyun Liu, Honglei Wang, Rong Fu

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui LiuDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID 0000-0002-1969-6015
Lijie ZengDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Chaomeng WangDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Yingying ChenDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Liyan LiDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID 0000-0003-2732-3646
Zhaoyun LiuDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID 0000-0002-2730-1562
Honglei WangDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Rong FuDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, China.ORCID 0000-0002-9928-9224

Funding

National Natural Science Foundation of China 81770110National Natural Science Foundation of China 81970115National Natural Science Foundation of China 82000128National Natural Science Foundation of China 82400166:82270142Natural Science Foundation of Tianjin Municipality 18JCYBJC27200Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-028ATianjin Municipal Commission of Education Research Project 2022KJ236Tianjin Science and Technology Planning Project 24ZXGZSY00090
6 · The paper itself

Abstract

Secondary gene mutations are one of the main mechanisms underlying paroxysmal nocturnal haemoglobinuria (PNH) clone proliferation. Our previous studies showed that SUZ12 participates in PNH clone proliferation by regulating H3K27me3. However, the mechanism underlying the SUZ12 function remains unclear. Immunoprecipitation and mass spectrometry were used to identify SUZ12 interacting proteins in PIGA-KO K562 cells. Furthermore, RNA-seq was used to explore the signalling pathways. Finally, colony formation assays, western blotting, and flow cytometry were performed to determine the proliferative ability of the cells. We identified 59 potential proteins that interact with SUZ12 and revealed a physical interaction between MIB2 and SUZ12 exclusively in the K562-KO cell line. Furthermore, we emphasise the vital involvement of the MIB/HERC and ZZ-type domains in the physical association between MIB2 and SUZ12. After MIB2 knockdown, SUZ12 protein decreased while the ubiquitination levels of SUZ12 were enhanced. Additionally, PRC2-related target genes were upregulated in the siMIB2 group. SUZ12 and H3K27me3 expression levels and cell proliferation significantly decreased after MIB2 knockdown, whereas cell apoptosis significantly increased. MIB2 protein levels are also elevated in patients with PNH. In conclusion, MIB2 affects the stability of the PRC2 complex by mediating SUZ12 ubiquitination, which in turn regulates PNH clone proliferation.

Indexed as

Polycomb Repressive Complex 2UbiquitinationUbiquitin-Protein LigasesApoptosisCell ProliferationHistonesHumansK562 CellsNeoplasm ProteinsTranscription FactorsHistonesNeoplasm ProteinsPolycomb Repressive Complex 2SUZ12 protein, humanTranscription FactorsUbiquitin-Protein LigasesMIB2paroxysmal nocturnal haemoglobinuriaPRC2 complexproliferationSUZ12

Identifiers

PMID40478202
PMCPMC12143176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.